A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. (Q46861089)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

title

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

attention deficit hyperactivity disorder

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

Boukje A G Dijkstra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Pieter J Carpentier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

Cor A J de Jong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

Cor A G Verbrugge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1868-1874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16367988 AND SRC:MED&resulttype=core&format=json

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1360-0443.2005.01272.X

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1360-0443.2005.01272.X

Development of diagnostic checklists for use in routine clinical care. A guideline designed to assess DSM-III-R diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1360-0443.2005.01272.X

Methylphenidate effects on symptoms of attention deficit disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1360-0443.2005.01272.X

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1360-0443.2005.01272.X

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1360-0443.2005.01272.X